Loading...
01/11 16:20
Loading...
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The company reported strong financial performance with significant revenue and profit growth, driven by AI integration. Enhanced shareholder returns through increased dividends and share repurchases are positive signals. Despite potential risks like regulatory hurdles and economic uncertainties, the optimistic guidance and operational efficiency improvements outweigh concerns. The sentiment from the Q&A section did not provide additional negative insights to alter the positive outlook.
Quarterly Revenue CNY 840 million, up 23.9% year-on-year. The increase was driven by the integration of AI with the insurance and healthcare sectors, which improved operational efficiency.
Operating Profit 85.9% year-on-year increase. This was attributed to significant improvements in operational efficiency powered by AI.
Operating Margin Improved by 3.9 percentage points year-over-year, driven by deeper AI integration.
First Year Premium (FYP) CNY 3.2 billion, up 80.2% year-over-year and 53.1% quarter-over-quarter. Growth was driven by technological innovation and AI-driven customer acquisition.
Insurance-related Revenue CNY 740 million, up 28.7% year-over-year and 12.2% quarter-over-quarter. This was supported by deeper AI integration and increased investment in customer acquisition.
Short-term Products FYP CNY 2.43 billion, up 95% year-over-year and 62.1% quarter-over-quarter. Growth was driven by increased investment in customer acquisition and AI capabilities.
Products for People with Preexisting Conditions Quarterly premium of CNY 300 million, a year-on-year increase of 146.6%. This was due to the introduction of innovative insurance products.
Long-term FYP CNY 770 million, a year-on-year increase of 45.4% and sequential increase of 30.5%. Growth was supported by AI tools improving efficiency for online sales consultants and planners.
Digital Clinical Trial Solutions Revenue RMB 27.7 million, a year-on-year increase of 34.2%. Growth was driven by the rapid scale-up and efficiency gains in the digital clinical trial business.
Total Revenue RMB 838 million, representing a year-on-year increase of 23.9% and a quarter-on-quarter increase of 11.2%. Growth was attributed to AI-driven efficiency improvements in customer acquisition, sales, service, and quality control.
Operating Costs and Expenses RMB 741 million, an 18.7% increase year-over-year. The growth rate of costs and expenses was lower than that of revenue, indicating improved operational efficiency.
Sales and Marketing Expenses RMB 199 million, a 26.3% increase year-over-year. This was primarily due to increased marketing expenses for third-party traffic channels.
General and Administrative Expenses RMB 73.4 million, a decrease of 21.9% year-over-year. This was due to tightened operational control and reduced allowance for credit losses.
R&D Expenses RMB 51.9 million, remaining stable year-over-year. Resources were allocated to AI capabilities building.
Net Profit Attributable to Shareholders RMB 140 million, up 58.7% year-over-year. This was supported by robust operational capability and effective synergy among business segments.
Cash Reserves RMB 3.4 billion as of June 30, 2025, with positive operating cash flow, providing a solid foundation for growth and strategic investment.
Waterdrop Guardian AI application suite: Rolled out across customer acquisition, sales, underwriting, customer service, and quality assurance, leading to an 80% year-over-year increase in FYP and significant productivity improvements.
New insurance products: Introduced long-term medical plans like Xin Yi Bao, Huiminbao, and maternity insurance Jiehaoyun, catering to diverse customer needs, including those with pre-existing conditions.
KEYI.AI: Launched as an insurance-focused platform providing expert underwriting answers with high accuracy.
E-Find Platform: Expanded collaboration to 198 pharmaceutical and contract research organizations, enrolling 999 patients in Q2 2025, a historic high.
Waterdrop Co-Help: Launched in partnership with Guangzhou Civil Affairs Bureau, integrating social and public welfare resources to target populations effectively.
AI integration: Improved operational efficiency, driving an 85.9% year-over-year increase in operating profit and enhancing operating margin by 3.9 percentage points.
AI-driven customer acquisition: Enhanced user outreach and recommendation models, achieving a 155% increase in insurance premiums in Q2 compared to Q1.
AI customer service: Achieved 100% AI coverage for online insurers, handling 250,000 service sessions in June alone.
Shareholder returns: Approved a $10.9 million enhanced cash dividend and authorized a fifth annual share repurchase plan, repurchasing approximately $109 million worth of ADS since 2021.
AI technology advancements: Filed 60 patent applications related to large language models, with 9 filed internationally, and received recognition from Harvard Business School.
Market Conditions: Potential risks and uncertainties include those outlined in public filings with the SEC, which may cause actual results to differ materially from current expectations.
Regulatory Hurdles: The company operates under the safe harbor provision of U.S. Private Securities and the Litigation Reform Act of 1995, indicating potential regulatory compliance challenges.
Supply Chain Disruptions: Increased costs in referral and service fees, as well as marketing expenses for third-party traffic channels, suggest potential inefficiencies or disruptions in operational processes.
Economic Uncertainties: The company has been enhancing its AI capability to attract more users, which involves significant investment and could be impacted by broader economic conditions.
Strategic Execution Risks: The company is heavily reliant on AI-driven innovations and technological advancements, which may pose risks if these technologies fail to deliver expected results or face implementation challenges.
Revenue Growth: Looking ahead, the company aims to build on its current performance and achieve its business goals for 2025, focusing on medium and long-term business development.
AI Integration: The company plans to continue expanding the use of AI in the insurance and healthcare sectors, leveraging its self-developed multi-agent collaboration framework and other AI tools to improve operational efficiency and customer service.
Insurance Business Expansion: The company intends to further enhance its AI-driven customer acquisition and conversion models, expand its product portfolio, and improve the efficiency of online sales consultants and planners. It also plans to scale its AI customer service agent and quality control assistance.
Healthcare Business Growth: The company aims to deepen its large language model (LLM) capabilities and algorithmic precision to support the growth of its digital clinical trial and omnichannel marketing businesses.
Shareholder Returns: The company has approved an enhanced cash dividend and a fifth annual share repurchase plan to create more value for shareholders.
Enhanced Cash Dividend: The Board approved an enhanced cash dividend of $10.9 million, representing a 50% increase over the previous dividend. The dividend per ordinary share and per ADS is $0.03.
Annual Share Repurchase Plan: The Board authorized a fifth annual share repurchase plan. Since the first program in 2021, approximately 55.7 million ADS have been repurchased for $109 million as of August 31, 2025.
The company reported strong financial performance with significant revenue and net profit growth, driven by AI integration and business expansion. Despite increased operating costs, profitability improved, supported by shareholder returns through dividends and share repurchases. However, risks include rising expenses and regulatory uncertainties, but optimistic guidance and strategic AI investments suggest positive sentiment. The absence of any negative sentiment from the Q&A further supports a positive outlook.
The company reported strong financial performance with significant revenue and profit growth, driven by AI integration. Enhanced shareholder returns through increased dividends and share repurchases are positive signals. Despite potential risks like regulatory hurdles and economic uncertainties, the optimistic guidance and operational efficiency improvements outweigh concerns. The sentiment from the Q&A section did not provide additional negative insights to alter the positive outlook.
The earnings call highlights strong financial performance, including a significant increase in net profit and stable operating margins. The company is expanding AI investments and partnerships, which are positive for future growth. Shareholder returns through dividends and share repurchases further boost sentiment. Despite some regulatory and competitive risks, the overall outlook remains positive with strategic investments and a solid cash position supporting growth. The absence of significant concerns in the Q&A session reinforces this sentiment.
The earnings call reflects strong financial performance with substantial revenue and profit growth, supported by strategic AI investments and shareholder returns through dividends and repurchases. Despite regulatory and competitive risks, the company's robust cash position and operational efficiency improvements suggest positive momentum. The market is likely to react positively, driven by optimistic growth outlooks and strategic initiatives.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
